ABACUS (ABL) ALERT: Bragar Eagel & Squire, P.C. is Investigating Abacus Global Management, Inc. on Behalf of Abacus Stockholders and Encourages Investors to Contact the Firm If you purchased or acquired stock in Abacus and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at […]

JIVA Technologies Inc. (CSE: JIVA) (Frankfurt: WNT1) (OTCQB: PLTXF) (“JIVA” or the “Company”) announces that it will miss its filing deadline of July 29, 2025 to file audited annual financial statements and accompanying management's discussion and analysis and related CEO and CFO certificates for the financial year ended March 31, 2025 (collectively, the “Annual Filings”),

(NASDAQ:FAT),(NasdaqGM:TWNP), LOS ANGELES, July 29, 2025 (GLOBE NEWSWIRE) — The United States Attorney for the Central District of California has filed a motion to dismiss all charges against Andrew “Andy” Wiederhorn, FAT Brands Inc. (NASDAQ: FAT), Rebecca Hershinger, and William Amon. Mr. Wiederhorn and his legal team have consistently maintained his innocence, and that the

U.S. Department of Justice Drops All Charges Against Andrew Wiederhorn, FAT Brands, William Amon, and Rebecca Hershinger GlobeNewswire July 30, 2025 LOS ANGELES, July 29, 2025 (GLOBE NEWSWIRE) — The United States Attorney for the Central District of California has filed a motion to dismiss all charges against Andrew “Andy” Wiederhorn, FAT Brands Inc. (NASDAQ:

NEW YORK, NY / ACCESS Newswire / July 29, 2025 / If you suffered a loss on your iRobot Corporation (NASDAQ:IRBT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/irobot-corporation-lawsuit-submission-form?prid=158753&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Harbour BioMed (HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology and oncology, today announced that it will present Phase II clinical data on its next-generation, fully human heavy-chain-only anti-CTLA-4 antibody, porustobart (HBM4003), in combination with tislelizumab, for the treatment of microsatellite stable (MSS) metastatic colorectal

SAN DIEGO, July 29, 2025 (GLOBE NEWSWIRE) — Quick Custom Intelligence (QCI), the global leader in AI and analytics for the casino industry, today announced a 50% organic growth through June 2025 compared to the prior 12 months, underscoring the company's sustained momentum since its founding in March 2020 by Dr. Ralph Thomas and Andrew

QCI Posts 50% Organic Growth Over Prior Year; Accelerated Global Expansion Across Australia and Asia and Acquisition of VizExplorer Set to Drive Further Gains GlobeNewswire July 30, 2025 SAN DIEGO, July 29, 2025 (GLOBE NEWSWIRE) — Quick Custom Intelligence (QCI), the global leader in AI and analytics for the casino industry, today announced a 50%

NEW YORK, NY / ACCESS Newswire / July 29, 2025 / If you suffered a loss on your Hims & Hers Health, Inc. (NYSE:HIMS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/hims-hers-health-inc-lawsuit-submission-form?prid=158752&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq. via email at

Reflection Family Interventions and The Family Recovery Foundation Launch Groundbreaking 24-Week Family Recovery Curriculum PHOENIX, AZ / ACCESS Newswire / July 29, 2025 / What should you do when a loved one refuses help for addiction or mental illness? For families caught in the chaos of crisis, the traditional answer-"wait until they hit bottom"-has caused